Umberto Capece
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
A Four-Week Treatment With Dapagliflozin Is Associated With a Reduction in Insulin-Stimulated Renal Cortical Glucose Uptake: A Post Hoc Analysis From a Pilot Study.
Journal: Diabetes, obesity & metabolism
Published: February 06, 2026
Euthyroid Sick Syndrome (ESS) and Monocyte-to-Lymphocyte Ratio (MLR) Are Predictors of Complications in Geriatric Hip Fractures: A Single-Center Retrospective Analysis.
Journal: Journal of clinical medicine
Published: February 04, 2026
Oxidative Stress in Diabetic Cardiomyopathy: Molecular Mechanisms and Emerging Therapeutic Targets.
Journal: Biomolecules
Published: January 31, 2026
Impact of the Friedewald equation vs 2 validated equations on LDL-C estimates and goal achievement in hospitalized patients with diabetes.
Journal: Journal of clinical lipidology
Published: November 05, 2025
The role of noradrenergic innervation and β-cell dedifferentiation in diabetes.
Journal: Trends in endocrinology and metabolism: TEM
Published: September 30, 2025
Illuminating Glucose: How to Unveil Organ-Specific Insulin Resistance and Guide Metabolic Strategies in Diabetes.
Journal: Diabetes/metabolism research and reviews
Published: June 20, 2025
Coronary flow reserve increase after 4-year dapagliflozin treatment in patients with type 2 diabetes: the DAPAHEART follow-up study.
Journal: Cardiovascular diabetology
Published: May 27, 2025
Corrigendum to "In humans increase in intrapancreatic adipose tissue predicts beta-cell dedifferentiation score before diabetes onset: A pilot study" [Diabetes Res. Clin. Pr. 221 (2025) MS N. 112029].
Journal: Diabetes research and clinical practice
Published: March 18, 2025
In humans increase in intrapancreatic adipose tissue predicts beta-cell dedifferentiation score before diabetes onset: A pilot study.
Journal: Diabetes research and clinical practice
Published: November 14, 2024
Erythrocyte Membrane Fluidity and Omega-3 Fatty Acid Intake: Current Outlook and Perspectives for a Novel, Nutritionally Modifiable Cardiovascular Risk Factor.
Journal: Nutrients
Published: November 11, 2024
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives.
Journal: Cardiovascular diabetology
Published: October 18, 2024
Real-world evidence evaluation of LDL-C in hospitalized patients: a population-based observational study in the timeframe 2021-2022.
Journal: Lipids in health and disease
Published: May 10, 2024
Last Updated: 09/26/2026